Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yoshikazu, Hirano"'
Publikováno v:
Case Reports in Medicine, Vol 2013 (2013)
We describe an unusual case of renal cell carcinoma (RCC) involving the entire upper urinary tract. A 51-year-old female was referred to us because of macroscopic hematuria. Computed tomography revealed a renal tumor filling renal pelvis and ureter,
Externí odkaz:
https://doaj.org/article/b7c6461d82284a23b624789f92d2143f
Autor:
Haruki Kume, Tetsuya Fujimura, Taketo Kawai, Satoru Taguchi, Yoshimitsu Komemushi, Akihiko Matsumoto, Yoshinori Tanaka, Yukari Uemura, Hideyo Miyazaki, Yukio Homma, Yasuhiko Igawa, Tohru Nakagawa, Hiroshi Fukuhara, Atsushi Kanatani, Yoshikazu Hirano, Jimpei Miyakawa, Akihiro Naito, Motofumi Suzuki, Hiroaki Nishimatsu, Masafumi Otsuka
Publikováno v:
World Journal of Urology. 35:1569-1575
To evaluate the efficacy of adjuvant systemic chemotherapy for locally advanced (pT3-4pN0/xM0) upper tract urothelial carcinoma (UTUC). We retrospectively reviewed the medical records of 109 patients with pT3-4pN0/xM0 UTUC who had undergone radical n
Autor:
Satoru Taguchi, Akihiko Matsumoto, Taketo Kawai, Tetsuya Fujimura, Yoshimitsu Komemushi, Yoshinori Tanaka, Masaomi Ikeda, Yasuhiko Igawa, Hiroaki Nishimatsu, Yasushi Nagase, Haruki Kume, Yukio Homma, Yasushi Kondo, Daisuke Yamada, Yutaka Enomoto, Toshikazu Okaneya, Yoshikazu Hirano, Motofumi Suzuki, Atsushi Kanatani, Hideyo Miyazaki, Tohru Nakagawa, Hiroshi Fukuhara, Shinji Urakami, Jimpei Miyakawa
Publikováno v:
Annals of surgical oncology. 24(9)
Resection of metastatic lesions (metastasectomy) is performed for highly selected patients with metastatic urothelial carcinoma (mUC). This study aimed to identify the clinicopathologic factors associated with oncologic outcome for patients who under
Autor:
Hideyo, Miyazaki, Yoshikazu, Hirano, Shinobu, Kato, Naomasa, Ioritani, Takaharu, Ichikawa, Hitoshi, Takamoto, Yukio, Homma
Publikováno v:
Lower urinary tract symptoms. 10(3)
We report early experiences of contact laser vaporization of the prostate for symptomatic benign prostatic hyperplasia (BPH).A total of 80 patients recruited at four institutions in Japan from April 2013 through September 2014 underwent contact laser
Autor:
Haruki Kume, Hiroaki Nishimatsu, Hiroshi Fukuhara, Yukio Homma, Tetsuya Fujimura, Yoshikazu Hirano, Daisuke Yamada, Shintaro Kumano, Motofumi Suzuki, Yutaka Enomoto
Publikováno v:
International Journal of Urology. 20:1220-1227
Objectives Quinazoline-based α1-adrenoceptor antagonists are known to inhibit prostate tumor growth through induction of apoptosis. We investigated the effect of a naphthalene-based α1-adrenoceptor antagonist, naftopidil, on prostate cancer inciden
Autor:
Akihiko Matsumoto, Toshikazu Okaneya, Hiroaki Nishimatsu, Yutaka Enomoto, Daisuke Yamada, Yukio Homma, Atsushi Kanatani, Taketo Kawai, Masayoshi Nagata, Tetsuya Fujimura, Yukari Uemura, Satoru Taguchi, Yasushi Nagase, Akira Ishikawa, Yasuhiko Igawa, Yasushi Kondo, Mitsuru Shinohara, Motofumi Suzuki, Haruki Kume, Masaomi Ikeda, Hideyo Miyazaki, Tohru Nakagawa, Hiroshi Fukuhara, Yoshikazu Hirano, Yoshimitsu Komemushi, Yoshinori Tanaka, Kanae Yoshida
Publikováno v:
Urologic oncology. 35(7)
Purpose We aimed to identify prognostic clinicopathological factors and to create a nomogram able to predict overall survival (OS) in recurrent urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC). Materials and methods Among 1,087
Autor:
Yasushi Kondo, Atsushi Kanatani, Shinji Urakami, Kanae Yoshida, Satoru Taguchi, Yutaka Enomoto, Shigeru Minowada, Akihiko Matsumoto, Daisuke Yamada, Yukio Homma, Taketo Kawai, Tetsuya Fujimura, Hiroaki Nishimatsu, Yasushi Nagase, Masaomi Ikeda, Toshikazu Okaneya, Haruki Kume, Hideyo Miyazaki, Tohru Nakagawa, Hiroshi Fukuhara, Motofumi Suzuki, Yoshimitsu Komemushi, Yoshinori Tanaka, Yoshikazu Hirano
Publikováno v:
Journal of Urology. 195
Autor:
Hiroaki Nishimatsu, Hideyo Miyazaki, Yoshikazu Hirano, Hiroshi Fukuhara, Yukio Homma, Yutaka Enomoto, Yasuhiko Igawa, Motofumi Suzuki, Haruki Kume, Akira Ishikawa, Tetsuya Fujimura
Publikováno v:
BJU International. 110:E520-E525
Study Type – Harm (case series) Level of Evidence 4 What's known on the subject? and What does the study add? The common clinical practice for advanced prostatic adenocarcinoma is combination therapy of zoledronic acid (ZA) and docetaxel (TAX). Lit
Autor:
Hiroaki Nishimatsu, Hiromasa Horiguchi, Yoshikazu Hirano, Toru Sugihara, Yukio Homma, Hideo Yasunaga, Shinya Matsuda
Publikováno v:
BJU International. 110:E332-E338
OBJECTIVE To assess clinical and mechanical risk factors of clinically significant renal haemorrhage after extracorporeal shock wave lithotripsy (ESWL). PATIENTS AND METHODS Patient data were extracted from the Diagnosis Procedure Combination (DPC) d
Autor:
Masato Sakai, Shinichi Teshima, Jinpei Kumagai, Shunichi Ono, Takeshi Kawamura, Yoshikazu Hirano, Hirohito Kobayashi, Shigehiko Inoue
Publikováno v:
The Japanese Journal of Urology. 96:462-465
We report a case of prostatic cystadenoma. A 81-year-old man visited our hospital with the chief complaint of urinary difficulty. RUG and DIP showed bladder and prostatic urethra deviated to the left side. TRUS, CT and MRI revealed multilocular cyst